|
|
| | Stapokibart Basic information |
| | Stapokibart Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Stapokibart Usage And Synthesis |
| Uses | Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats[1]. | | References | [1] Yuan Zhang, et al. Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial. EClinicalMedicine. 2023 Jul 5:61:102076. DOI:10.1016/j.eclinm.2023.102076 |
| | Stapokibart Preparation Products And Raw materials |
|